BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37831393)

  • 1. Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus.
    Chang KH; Chen CM; Lin CN; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Weng YC; Hwang JS; Kuo HC
    J Peripher Nerv Syst; 2023 Dec; 28(4):651-663. PubMed ID: 37831393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
    Xu J; Cai M; Wang Z; Chen Q; Han X; Tian J; Jin S; Yan Z; Li Y; Lu B; Lu H
    J Endocrinol Invest; 2023 May; 46(5):869-882. PubMed ID: 36282471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-high performance liquid chromatography coupled to tandem mass spectrometry-based metabolomics study of diabetic distal symmetric polyneuropathy.
    Xu J; Chen Q; Cai M; Han X; Lu H
    J Diabetes Investig; 2023 Sep; 14(9):1110-1120. PubMed ID: 37347226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy.
    Maalmi H; Strom A; Petrera A; Hauck SM; Strassburger K; Kuss O; Zaharia OP; Bönhof GJ; Rathmann W; Trenkamp S; Burkart V; Szendroedi J; Ziegler D; Roden M; Herder C;
    Diabetologia; 2023 Mar; 66(3):579-589. PubMed ID: 36472640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.
    Weng YC; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Chen CM; Hwang JS; Kuo HC
    J Diabetes Res; 2020; 2020():6356459. PubMed ID: 32695829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study.
    Herder C; Thorand B; Strom A; Rathmann W; Heier M; Koenig W; Morrison H; Ziegler D; Roden M; Peters A; Bönhof GJ; Maalmi H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3807. PubMed ID: 38872492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of high-dose intramuscular vitamin D
    Chen T; Xing X; Huang L; Tu M; Lai X; Wen S; Cai J; Lin S; Zheng Y; Lin Y; Xu L; Qiu Y; Qiu L; Xu Y; Wu P
    Front Endocrinol (Lausanne); 2023; 14():1202917. PubMed ID: 37484958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy.
    Ziegler D; Strom A; Bönhof GJ; Kannenberg JM; Heier M; Rathmann W; Peters A; Meisinger C; Roden M; Thorand B; Herder C
    BMJ Open Diabetes Res Care; 2019; 7(1):e000752. PubMed ID: 31803481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.
    Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
    Curr Vasc Pharmacol; 2020; 18(1):50-56. PubMed ID: 30156161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes.
    Lai YR; Chiu WC; Huang CC; Cheng BC; Kung CT; Lin TY; Chiang HC; Tsai CJ; Kung CF; Lu CH
    Neurophysiol Clin; 2024 Jul; 54(4):102982. PubMed ID: 38761793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
    Herder C; Kannenberg JM; Huth C; Carstensen-Kirberg M; Rathmann W; Koenig W; Strom A; Bönhof GJ; Heier M; Thorand B; Peters A; Roden M; Meisinger C; Ziegler D
    Diabetes Metab Res Rev; 2018 Jul; 34(5):e3000. PubMed ID: 29577557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.
    Tsilingiris D; Schimpfle L; von Rauchhaupt E; Sulaj A; Seebauer L; Herzig S; Szendroedi J; Kopf S; Κender Ζ
    Diabetes; 2024 Jan; 73(1):135-146. PubMed ID: 37862374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum bilirubin levels contribute to the presence and progression of distal symmetrical polyneuropathy in Chinese patients with type 2 diabetes.
    Jin J; Wang W; Gu T; Chen C; Sun J; Chen W; Bi Y; Zhu D
    Diabetes Metab; 2019 Jan; 45(1):47-52. PubMed ID: 29555465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends in Distal Symmetric Polyneuropathy in Type 2 Diabetes: The Fremantle Diabetes Study.
    Davis WA; Hamilton E; Davis TME
    J Clin Endocrinol Metab; 2024 Feb; 109(3):e1083-e1094. PubMed ID: 37930807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms (Pro197Leu of Gpx1, +35A/C of SOD1, -262C/T of CAT), the level of antioxidant proteins (GPx1, SOD1, CAT) and the risk of distal symmetric polyneuropathy in Polish patients with type 2 diabetes mellitus.
    Kasznicki J; Sliwinska A; Kosmalski M; Merecz A; Majsterek I; Drzewoski J
    Adv Med Sci; 2016 Mar; 61(1):123-9. PubMed ID: 26674569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy.
    Xiong Q; Lu B; Ye HY; Liu SY; Zheng HP; Zhang RY; Qiao XN; Zhang S; Liu XX; Li QC; Yi N; Wu LC; Wen J; Zhang TS; Li YM
    Diabetes Res Clin Pract; 2018 Feb; 136():85-92. PubMed ID: 29221815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Composite nerve conduction scores and signs for diagnosis and somatic staging of diabetic polyneuropathy: Mid North American ethnic cohort survey.
    Davies JL; Lodermeier KA; Klein DM; Carter RE; Dyck PJB; Litchy WJ; Dyck PJ
    Muscle Nerve; 2023 Jul; 68(1):29-38. PubMed ID: 36734298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.